Disclosure of interests
HT and J-HL report being investigators of an ongoing multicenter trial
regarding SLNB in cervical cancer (CSEM 010, NCT02642471) funded by a
government project (Health and Medical Cooperation Innovation Special
Program of Guangzhou Municipal Science and Technology, grant number:
158100075). J-HL receives lecture fees from AstraZeneca and Roche,
outside the submitted work. All other authors declare no competing
interests.